Duchenne / Becker Muscular Dystrophy Clinical Trials
2 recruiting trials for Duchenne / Becker Muscular Dystrophy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Duchenne / Becker Muscular Dystrophy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University Hospital, Clermont-Ferrand (1), Boston Children's Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is dosage of blood biomarker miR1 (diagnostic_test, 1 trial).
Track Duchenne / Becker Muscular Dystrophy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies
The study aims to find out if a specific blood molecule called miR-1, can be used as a biomarker to track the health of patients with certain muscle diseases. MicroRNAs (miRs)...
Molecular Analysis of Patients With Neuromuscular Disease
The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Duchenne / Becker Muscular Dystrophy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Duchenne / Becker Muscular Dystrophy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Duchenne / Becker Muscular Dystrophy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.